Drug Safety Canada

October 19, 2009 08:49 ET

Drug Safety Canada seeks standing at Carlin Inquest

Terence Young, now MP, founded Drug Safety Canada to promote safe use of prescription drugs

Attention: Assignment Editor, City Editor, Health/Medical Editor, News Editor, Government/Political Affairs Editor OAKVILLE, ONTARIO, MEDIA RELEASE--(Marketwire - Oct. 19, 2009) - On Tuesday October 20, 2009 at 10 a.m. there will be a hearing at the Coroner's Court in Toronto to determine if Terence Young and Drug Safety Canada can participate with standing in the November 2nd inquest in to the death of Sara Carlin of Oakville.

Sara Carlin, age eighteen died on May 7, 2007 in her family home in Oakville after withdrawing from the GlaxoSmithKline prescription antidepressant Paxil.
Sara hung herself in the basement of her home.

Drug Safety Canada is a non-profit organization formed to promote the safe use of prescription drugs, founded in 2002 by Terence Young, now Member of Parliament for Oakville in the aftermath of the death of his fifteen year old daughter Vanessa due to heart arrhythmia caused by the Johnson & Johnson prescription drug Prepulsid.

Drug Safety Canada is seeking standing at this inquest to represent the public interest in ensuring that only safe prescription drugs are given to patients, and only under safe conditions, offering unique perspective to assist the Coroner's jury make recommendations with regards to the adequacy of prescription drug safety warnings,
a key issue in the death of Sara Carlin.

Paxil is an SSRI antidepressant in the same class as Prozac, which is known to cause suicide in youth. Under the name Seroxat, Paxil was the source of a three year criminal investigation in the U.K. related to a cover-up of the risk of suicide in youth. GlaxoSmithKline paid $ 2.5 M to settle law suit claims by the State of New York that they had 'engaged in a repeated and persistent fraud by concealing and failing to disclose information concerning Paxil's safety and efficacy for children.' /For further information: Alternate Contact: Peter Rosenthal, the lawyer representing Drug Safety Canada at 416-978-3093/ IN: HEALTH, OTHER

Contact Information